These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1794823)

  • 1. [Effect of anti-glaucoma eyedrops on cell differentiation of the conjunctiva].
    Steuhl KP; Knorr M; Frohn A; Thiel HJ
    Fortschr Ophthalmol; 1991; 88(6):865-9. PubMed ID: 1794823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies.
    Baudouin C; Pisella PJ; Fillacier K; Goldschild M; Becquet F; De Saint Jean M; Béchetoille A
    Ophthalmology; 1999 Mar; 106(3):556-63. PubMed ID: 10080214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effects of topical antiglaucomatous medications on the conjunctiva and the lachrymal (Brit. Engl) response.
    Nuzzi R; Finazzo C; Cerruti A
    Int Ophthalmol; 1998; 22(1):31-5. PubMed ID: 10090446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of preservatives on the conjunctiva: a comparative study of beta-blocker eye drops with and without preservatives in glaucoma patients].
    Pisella PJ; Lala E; Parier V; Brignole F; Baudouin C
    J Fr Ophtalmol; 2003 Sep; 26(7):675-9. PubMed ID: 13130254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Flow cytometric analysis of HLA-DR, IL-6 and IL-8 expression by conjunctival epithelial cells from patients with prolonged topical antiglaucoma treatments].
    Bensoussan L; Blondin C; Baudouin C; Hamard P; Sabeh Afaki G; Creuzot-Garcher C; Warnet JM; Brignole-Baudouin F
    J Fr Ophtalmol; 2003 Oct; 26(8):782-9. PubMed ID: 14586218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears.
    Kahook MY; Noecker RJ
    Cornea; 2008 Apr; 27(3):339-43. PubMed ID: 18362664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modification of tear film break-up time by beta blocker eyedrops without preservatives].
    Marquardt R; Schubert T
    Klin Monbl Augenheilkd; 1991 Aug; 199(2):75-8. PubMed ID: 1960936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Structural and immunohistochemical changes of conjunctiva induced by topical glaucoma medication].
    Nenciu A; Stefan C; Ardelean C
    Oftalmologia; 2004; 48(1):35-42. PubMed ID: 15279417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Conjunctival changes in long-term topical drug therapy of glaucoma].
    Cvetković D; Parunović A; Kontić D
    Fortschr Ophthalmol; 1986; 83(4):407-9. PubMed ID: 3095209
    [No Abstract]   [Full Text] [Related]  

  • 10. Do antiglaucomatous prostaglandins induce melanogenesis in human conjunctiva?: an impression cytology pilot study.
    Cagigrigoriu A; Boero E; Carenini AB; Rolle T; Cappia S; Bacillo E; Papotti M; Gregori D; Brovarone FV; Grignolo FM
    J Glaucoma; 2010 Jan; 19(1):44-50. PubMed ID: 20075674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ultrastructural changes in the conjunctiva of Cynomolgus monkeys following pilocarpine administration?].
    Steuhl KP; Rohrbach JM
    Klin Monbl Augenheilkd; 1988 Jun; 192(6):672-6. PubMed ID: 3210637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Toxicity of preserved and unpreserved beta-blocker eyedrops in an in vitro model of human conjunctival cells].
    de Saint Jean M; Debbasch C; Brignole F; Rat P; Warnet JM; Baudouin C
    J Fr Ophtalmol; 2000 Feb; 23(2):111-21. PubMed ID: 10705112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1beta tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockers.
    Manni G; Centofanti M; Oddone F; Parravano M; Bucci MG
    Am J Ophthalmol; 2005 Jan; 139(1):72-7. PubMed ID: 15652830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of failure in glaucoma filtering surgery: a consequence of antiglaucomatous drugs?
    Baudouin C
    Int J Clin Pharmacol Res; 1996; 16(1):29-41. PubMed ID: 9001927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of conjunctival goblet cells after chronic application of topical drops.
    Kahook MY; Noecker R
    Adv Ther; 2008 Aug; 25(8):743-51. PubMed ID: 18670744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glaucoma and the dry eye syndrome].
    Follmann P; Túri E
    Klin Monbl Augenheilkd; 1980 Jan; 176(1):147-52. PubMed ID: 7412153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of indomethacin 0.1% and fluorometholone 0.1% on conjunctival inflammation following chronic application of antiglaucomatous drugs.
    Baudouin C; Nordmann JP; Denis P; Creuzot-Garcher C; Allaire C; Trinquand C
    Graefes Arch Clin Exp Ophthalmol; 2002 Nov; 240(11):929-35. PubMed ID: 12486516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Goblet cell density modified by pilocarpine].
    Gerstenberger A; Marquardt R
    Fortschr Ophthalmol; 1986; 83(1):46-50. PubMed ID: 3710353
    [No Abstract]   [Full Text] [Related]  

  • 19. Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term.
    Baudouin C; Hamard P; Liang H; Creuzot-Garcher C; Bensoussan L; Brignole F
    Ophthalmology; 2004 Dec; 111(12):2186-92. PubMed ID: 15582072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of long-term topical glaucoma medication on conjunctival impression cytology.
    Turaçli E; Budak K; Kaur A; Mizrak B; Ekinci C
    Int Ophthalmol; 1997; 21(1):27-33. PubMed ID: 9298420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.